课题基金 / 基金详情

ORTHOTOPIC LIVER TRANSPLANTATION

ORTHOTOPIC LIVER TRANSPLANTATION
原位肝移植
批准号:
2391341
负责人:
THOMAS E STARZL
金额:
$65.61万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-01-01 至 2001-03-31

项目摘要

项目成果

THOMAS E STARZL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This application is designed to study the mechanisms of transplantation tolerance with particular reference to the liver. The principal hypothesis driving these studies if the Principal Investigator's so- called "Two-Way Paradigm". This proposes that the ultimate outcome of allograft transplantation represents the composite of two immunologic forces: classic host vs. graft attack, i.e. allograft rejection, and graft vs. host. The latter is an occult immunologic force at work. Although the clinical entity of graft vs. host disease in liver transplantation is uncommon, it represents in essence a serious effort by leukocytes contained in the graft to reject the recipient after their migration. Thus, it is the investigator's proposal that the recipient becomes populated with small numbers of cells from the donor organ and that the effect of this "graft vs. host" reaction is the promotion of tolerance. As these cells leave the graft, they are replaced in the transplant by immune cells of the recipient in successful cases. In this hypothesis, host vs. graft disease if uncontrolled is bad because it leads to rejection of the allograft. The other way round, graft vs. host disease if unchecked can kill the patient, but if controlled it tempers rejection. The studies proposed will test this hypothesis. Moreover, the investigators will attempt to develop novel techniques to modify the number and character of the donor cells that ultimately reside in the recipient and promote tolerance to the allograft.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GENE MODIFIED CLONED PIGS
GENE MODIFIED CLONED PIGS
GENE MODIFIED CLONED PIGS
GENE MODIFIED CLONED PIGS
海外基金